BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 861742)

  • 1. Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment.
    Olpe HR; Koella WP
    Brain Res; 1977 May; 126(3):576-9. PubMed ID: 861742
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP; Tsou K
    J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of intranigral microinjection of substance P on apomorphine-induced rotational behavior in 6-OHDA lesions rats].
    Jiao JJ; Gao DM; Zhuang XY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 Nov; 17(4):404. PubMed ID: 21207714
    [No Abstract]   [Full Text] [Related]  

  • 4. Substance P in the substantia nigra.
    Davies J; Dray A
    Brain Res; 1976 May; 107(3):623-7. PubMed ID: 1268746
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
    Kelley AE; Iversen SD
    Brain Res; 1978 Dec; 158(2):474-8. PubMed ID: 709379
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioural effects of tachykinins and related peptides.
    Elliott PJ; Iversen SD
    Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drinking behaviour induced by intracranial injections of eledoisin and substance P in the pigeon.
    Evered MD; Fitzsimons JT; De Caro G
    Nature; 1977 Jul; 268(5618):332-3. PubMed ID: 887160
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance P antagonists in substantia nigra are anticonvulsant.
    Garant DS; Iadarola MJ; Gale K
    Brain Res; 1986 Sep; 382(2):372-8. PubMed ID: 2428445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranigral injection of capsaicin enhances motor activity and depletes nigral 5-hydroxytryptamine but not substance P.
    Dawbarn D; Harmar AJ; Pycock CJ
    Neuropharmacology; 1981 Apr; 20(4):341-6. PubMed ID: 6170024
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological characterization of a substance P antagonist, [D-Arg1,D-Pro2,D-Trp7,9,Leu11]-substance P.
    Watson SP
    Br J Pharmacol; 1983 Sep; 80(1):205-9. PubMed ID: 6197127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of some vasoactive polypeptides and their antagonists on the anococcygeus muscle.
    Gillespie JS; McKnight AT
    Br J Pharmacol; 1978 Feb; 62(2):267-74. PubMed ID: 623939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible influence of tachykinins on body fluid homeostasis in the rat.
    Cantalamessa F; De Caro G; Massi M; Perfumi M
    J Physiol (Paris); 1984; 79(6):524-30. PubMed ID: 6085638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipsogenic effect of angiotensin II, bombesin and tachykinins in the duck.
    de Caro G; Mariotti M; Massi M; Micossi LG
    Pharmacol Biochem Behav; 1980 Aug; 13(2):229-33. PubMed ID: 6158059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotation induced by intranigral phenobarbital: evidence of barbiturate GABAergic activity.
    McDevitt JT; Yunger LM
    Pharmacol Biochem Behav; 1982 May; 16(5):737-9. PubMed ID: 6283567
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in amino acid sensitivity during polypeptide "desensitisation".
    Davies J; Dray A
    Nature; 1976 Aug; 262(5569):606-7. PubMed ID: 958426
    [No Abstract]   [Full Text] [Related]  

  • 16. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain.
    Herrera-Marschitz M; Terenius L; Sakurada T; Reid MS; Ungerstedt U
    Brain Res; 1990 Jun; 521(1-2):316-20. PubMed ID: 1698511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eledoisin, substance P and related peptides: intracranial dipsogens in the pigeon and antidipsogens in the rat.
    Fitzsimons JT; Evered MD
    Brain Res; 1978 Jul; 150(3):533-42. PubMed ID: 678989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP; Tsou K
    Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat.
    Cridland RA; Henry JL
    Brain Res; 1986 Aug; 381(1):93-9. PubMed ID: 2428434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
    Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.